We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
K* is the set of functions and processes at the various interfaces between knowledge, practice, and policy
A summary of what delivering better integrated care means and how Monitor is supporting the sector.
Your technology should adapt to future demands and work with existing technologies, processes and infrastructure in your organisation.
The New Active Substance Work Sharing Initiative (NASWSI) has successfully approved several medicines through this international collaboration and continues to foster cooperation and strong relationships between its Access partners. The Biosimilar Work Sharing Initiative (BSWSI) builds on this success.
How to find out information on our social impact activities and programmes.
Documents on the Growing Places Fund.
Foresight project looking at how changes in the next 10 years will affect views of identity in the UK.
Find out about the long-term effects some people can have after having COVID-19.
Explains key issues in implementing policy to protect and enhance the natural environment, including local requirements.
Remarks by Sarah Cardell, CEO of the CMA, delivered during the 72nd Antitrust Law Spring Meeting. Washington DC, USA.
Explore the impact of parental conflict on children and young people.
The CMA has outlined 3 key risks to effective competition on AI Foundation Models and has set out plans for further action in the market.
Statement by Deputy Foreign Secretary Andrew Mitchell at the United Nations General Assembly 57th session of the Commission on Population and Development.
An overview of the work the IPO is undertaking in relation to Standard Essential Patents.
The MHRA is part of the Access Consortium along with the Therapeutic Goods Administration, Health Canada, Health Sciences Authority of Singapore and Swissmedic.
How to use a contextual inquiry when developing your digital health product.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.